STUDY TO EVALUATE THE ANTIVIRAL ACTIVITY, CLINICAL OUTCOMES, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF ORALLY ADMINISTERED LUMICITABINE REGIMENS IN ADULT PARTICIPANTS HOSPITALIZED WITH RESPIRATORY SYNCYTIAL VIRUS: